3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
4
Prostatic Neoplasms
3
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neurocognitive Disorders
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin G4-Related Disease
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Autoimmune Pancreatitis
1
Anus Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
Cytarabine
5
Whole-Body Irradiation
4
fludarabine phosphate
3
fludarabine
3
Tacrolimus
3
Specimen Handling
3
Injections
3
Cyclophosphamide
3
CPX-351
3
Busulfan
3
Blood Specimen Collection
3
venetoclax
2
luspatercept
2
ivosidenib
2
decitabine and cedazuridine drug combination
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Methotrexate
2
Melphalan
2
Liposomes
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Gemtuzumab
2
Filgrastim
2
Daunorubicin
2
Cyclosporine
2
Biopsy
2
Azacitidine
2
tocilizumab
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Observation
×
30 days
×
Clear all
No trials found.